Cytosorbents Corp - Common Stock, $0.001 par value per share (CTSO)

Historical Holders from Q4 2014 to Q1 2025

Symbol
CTSO on Nasdaq
CUSIP
23283X206
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
54.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
15.2M
Holdings value
$14M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
51
Number of buys
21
Number of sells
-21
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cytosorbents Corp - Common Stock, $0.001 par value per share (CTSO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SATTERFIELD THOMAS A JR 6.56% $4M 4M Thomas A. Satterfield, Jr. Jan 13, 2025
VANGUARD GROUP INC 7.13% $3.9M 3.9M The Vanguard Group Dec 31, 2024
AVENIR CORP 5.7% $3.09M 3.09M AVENIR CORP Dec 31, 2024
Skylands Capital, LLC 4.8% -6% $3M $221K 3M +7.95% Skylands Capital, LLC Mar 31, 2025

Institutional Holders of Cytosorbents Corp - Common Stock, $0.001 par value per share (CTSO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 93.5K $93.5K +$33.5K $1.00 2
2024 Q4 15.2M $14M -$1.25M $0.91 51
2024 Q3 16.4M $24.6M -$179K $1.50 51
2024 Q2 16.4M $11.5M -$649K $0.70 44
2024 Q1 17.5M $16.6M -$401K $0.95 47
2023 Q4 17.9M $19.9M +$3.24M $1.11 50
2023 Q3 15.2M $28.5M -$164K $1.88 50
2023 Q2 15.2M $54.5M +$124K $3.59 57
2023 Q1 15.1M $51.1M +$1.74M $3.37 56
2022 Q4 14.6M $22.5M -$222K $1.55 46
2022 Q3 12.9M $17.6M -$1.32M $1.36 48
2022 Q2 14.2M $31.1M -$1.59M $2.19 62
2022 Q1 15.3M $48.9M +$170K $3.19 77
2021 Q4 17.6M $73.8M -$7.84M $4.19 87
2021 Q3 18.4M $149M +$7.09M $8.12 94
2021 Q2 17M $129M -$26.1K $7.55 95
2021 Q1 17.1M $149M -$1.69M $8.68 91
2020 Q4 17M $136M +$2.85M $7.97 86
2020 Q3 17.1M $137M +$46.4M $7.98 92
2020 Q2 11.2M $111M +$14.2M $9.90 88
2020 Q1 9.9M $76.5M +$8.99M $7.73 78
2019 Q4 8.9M $34.2M +$1.44M $3.85 68
2019 Q3 8.41M $42.3M -$822K $5.03 63
2019 Q2 8.39M $55.5M +$428K $6.61 63
2019 Q1 8.36M $63.3M -$402K $7.57 68
2018 Q4 8.65M $69.9M +$1.14M $8.08 82
2018 Q3 8.2M $106M +$5.04M $12.90 78
2018 Q2 7.72M $88M +$46.3M $11.40 71
2018 Q1 3.9M $27.5M +$5.64M $7.05 44
2017 Q4 3.18M $20.6M +$4.75M $6.50 42
2017 Q3 2.48M $15.4M +$3.76M $6.20 31
2017 Q2 1.94M $8.34M -$2.21M $4.30 30
2017 Q1 2.43M $10.9M +$4.45M $4.50 32
2016 Q4 1.59M $8.68M +$49.1K $5.45 36
2016 Q3 1.57M $10M -$1.21M $6.40 34
2016 Q2 1.77M $8.06M +$386K $4.55 33
2016 Q1 1.38M $5.39M -$36.2K $3.92 31
2015 Q4 1.38M $7.66M -$95.3K $5.57 38
2015 Q3 1.35M $8.51M +$664K $6.30 32
2015 Q2 1.22M $7.51M +$716K $6.14 28
2015 Q1 901K $11.9M +$7.84M $13.19 26
2014 Q4 394K $3.92M +$1.05M $9.96 9